Clinical Tools

DSM-5-TR Substance Use Disorder Criteria Tool

Check the 11 DSM-5-TR substance use disorder criteria for a chosen substance, get mild, moderate, or severe, add remission specifiers, and copy a note.

Open the SUD Tool

Runs free in your browser. Entries stay on your device and are not sent to a server.

What it does

This is a documentation aid for the DSM-5-TR substance use disorder criteria. Choose a substance and the 11 criteria fill in with examples specific to it. The substances are alcohol, cannabis, phencyclidine (PCP), other hallucinogens, inhalants, opioids, sedatives/hypnotics/anxiolytics, stimulants (with amphetamine-type, cocaine, or other as the type), tobacco, and other or unknown substances. You then tick each criterion met in the past 12 months.

Criteria and severity

The 11 criteria cover larger amounts or longer use than intended, unsuccessful efforts to cut down, time spent obtaining or recovering, craving, role failure, continued use despite social problems, activities given up, use in hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal. The tool counts the criteria met and assigns severity:

Criteria metResult
0–1Does not meet threshold for SUD
2–3Mild
4–5Moderate
6 or moreSevere

For phencyclidine, other hallucinogens, and inhalants, withdrawal (criterion 11) is marked not applicable and excluded, so the maximum is 10. Some examples note that tolerance during legitimately prescribed treatment alone does not count.

Specifiers

If full criteria were met before but are not met now, you can mark early/recent remission (at least 3 but under 12 months) or sustained remission (12 months or more); craving may still be present in either. Additional specifiers are "in a controlled environment" and "on maintenance therapy," with a field for the maintenance agent.

What the report includes

The EMR-ready summary lists the date, substance, criteria met out of the substance's maximum, each endorsed criterion, severity, remission status, specifiers, a diagnostic impression (for example "Opioid Use Disorder, moderate"), and any supporting notes. It leaves a blank for the ICD-10-CM code, to be chosen from a current coding guide. A final diagnosis still requires clinical judgment and a full evaluation.

About PsychoPharmRef

PsychoPharmRef is a free clinical psychopharmacology reference built by Jerad Shoemaker, MD for psychiatrists, residents, and medical students. All tools are evidence-based and designed for point-of-care clinical decision support.

  • 101 psychiatric medications with receptor binding, P450, dosing, and monitoring data
  • 65 interactive clinical tools, rating scales, and therapy-course modules
  • Receptor binding profiles with bar chart, heatmap, and treemap views
  • PK curve comparison, P450 interaction checking, and a QTc calculator with Tisdale risk scoring
  • Medication taper and cross-taper planners
  • 124 evidence-based clinical chapters

PsychoPharmRef Clinical Reference | A resource for medical professionals | Page updated October 23, 2026

This tool is intended for educational purposes for healthcare professionals. Clinical decision-making should incorporate individual patient assessment and current guidelines.

PsychoPharmRef Newsletter

Stay current with AI-assisted reviews of new psychiatric research, FDA approvals, and guideline updates.